FTC Sues to Block Amgen’s Acquisition of Horizon Therapeutics

The Federal Trade Commission is suing to block Amgen Inc.’s $28 billion acquisition of Horizon Therapeutics to prevent a monopoly in the market for d.rugs that treat critical ailments

admin